
Sign up to save your podcasts
Or


Dr. Guymer discusses the results of the FLUID study which investigated whether some residual sub retinal fluid can be tolerated in neovascular macular degeneration.
Full reference:
Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen. Guymer, Robyn H.Chang, Andrew et al. Ophthalmology, Volume 126, Issue 5, 723 - 734
By Keyvan Koushan, MD, FRCSC4.4
1111 ratings
Dr. Guymer discusses the results of the FLUID study which investigated whether some residual sub retinal fluid can be tolerated in neovascular macular degeneration.
Full reference:
Tolerating Subretinal Fluid in Neovascular Age-Related Macular Degeneration Treated with Ranibizumab Using a Treat-and-Extend Regimen. Guymer, Robyn H.Chang, Andrew et al. Ophthalmology, Volume 126, Issue 5, 723 - 734

30,795 Listeners

18 Listeners

97 Listeners

2,441 Listeners

112,401 Listeners

56,722 Listeners

2 Listeners

4 Listeners

8 Listeners

10 Listeners

50 Listeners

11 Listeners

465 Listeners

19 Listeners

1 Listeners